title: New and emerging therapies for the treatment of rheumatoid arthritis.
abstract: The introduction of tumor necrosis factor (TNF) inhibitors in the late 1990s significantly changed the therapeutic approach for rheumatoid arthritis (RA). With the approval of subsequent TNF inhibitors as well as other biologic agents effective in the management of RA, the treatment paradigm has become increasingly complex. This review examines the current literature regarding the efficacy and toxicity of these and other new anti-rheumatic therapies and discusses effective therapeutic strategies for their use.
authors: Division of Rheumatology and Immunology, Department of Internal Medicine, University of Nebraska Medical Center, Nebraska Medical Center, Omaha, NE, USA.
authors: Michael G
authors: MG
authors: Feely
keywords: DMARDs; abatacept; adalimumab; biologics; certolizumab; etancercept; golimumab; infliximab; rituximab; tocilizumab; tumor necrosis factor inhibitors